Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1970619144', 'doi': 'https://doi.org/10.1007/bf01957893', 'title': 'A simple in vitro method of characterizing narcotic antagonists', 'display_name': 'A simple in vitro method of characterizing narcotic antagonists', 'publication_year': 1972, 'publication_date': '1972-12-01', 'ids': {'openalex': 'https://openalex.org/W1970619144', 'doi': 'https://doi.org/10.1007/bf01957893', 'mag': '1970619144', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/4631833'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/bf01957893', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210219280', 'display_name': 'Experientia', 'issn_l': '0014-4754', 'issn': ['0014-4754'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320186', 'host_organization_name': 'Birkhäuser', 'host_organization_lineage': ['https://openalex.org/P4310320186', 'https://openalex.org/P4310319900', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Birkhäuser', 'Springer Science+Business Media', 'Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5055873476', 'display_name': 'Markus A. Rüegg', 'orcid': 'https://orcid.org/0000-0002-4974-9384'}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'M. Rüegg', 'raw_affiliation_strings': ['Biological Research Laboratories of the Pharmaceutical Division of Ciba-Geigy Ltd.'], 'affiliations': [{'raw_affiliation_string': 'Biological Research Laboratories of the Pharmaceutical Division of Ciba-Geigy Ltd.', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5087369581', 'display_name': 'R. Jaques', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'R. Jaques', 'raw_affiliation_strings': ['Biological Research Laboratories of the Pharmaceutical Division of Ciba-Geigy Ltd.'], 'affiliations': [{'raw_affiliation_string': 'Biological Research Laboratories of the Pharmaceutical Division of Ciba-Geigy Ltd.', 'institution_ids': ['https://openalex.org/I1283582996']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.074, 'has_fulltext': False, 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.796031, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '28', 'issue': '12', 'first_page': '1525', 'last_page': '1526'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9715, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9715, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Prenatal Exposure to Antiepileptic Drugs', 'score': 0.966, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11465', 'display_name': 'Mechanisms of Drug-Induced Hepatotoxicity', 'score': 0.9572, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/narcotic', 'display_name': 'Narcotic', 'score': 0.8277825}, {'id': 'https://openalex.org/keywords/narcotic-antagonists', 'display_name': 'Narcotic antagonists', 'score': 0.7641449}, {'id': 'https://openalex.org/keywords/narcotic-analgesics', 'display_name': 'Narcotic analgesics', 'score': 0.55952746}, {'id': 'https://openalex.org/keywords/population-pharmacokinetics', 'display_name': 'Population Pharmacokinetics', 'score': 0.485808}], 'concepts': [{'id': 'https://openalex.org/C2775849661', 'wikidata': 'https://www.wikidata.org/wiki/Q940', 'display_name': 'Narcotic', 'level': 2, 'score': 0.8277825}, {'id': 'https://openalex.org/C2910878864', 'wikidata': 'https://www.wikidata.org/wiki/Q908096', 'display_name': 'Narcotic antagonists', 'level': 5, 'score': 0.7641449}, {'id': 'https://openalex.org/C2910783051', 'wikidata': 'https://www.wikidata.org/wiki/Q427523', 'display_name': 'Narcotic analgesics', 'level': 3, 'score': 0.55952746}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4910438}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3816768}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.3497609}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.30835986}, {'id': 'https://openalex.org/C2777389121', 'wikidata': 'https://www.wikidata.org/wiki/Q81225', 'display_name': 'Morphine', 'level': 2, 'score': 0.1474692}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.10735649}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.07882571}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.0601106}, {'id': 'https://openalex.org/C2778750930', 'wikidata': 'https://www.wikidata.org/wiki/Q4540629', 'display_name': '(+)-Naloxone', 'level': 4, 'score': 0.04320386}], 'mesh': [{'descriptor_ui': 'D009119', 'descriptor_name': 'Muscle Contraction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D009292', 'descriptor_name': 'Narcotic Antagonists', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': True}, {'descriptor_ui': 'D000109', 'descriptor_name': 'Acetylcholine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000109', 'descriptor_name': 'Acetylcholine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000109', 'descriptor_name': 'Acetylcholine', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000700', 'descriptor_name': 'Analgesics', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001095', 'descriptor_name': 'Arachidonic Acids', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D001095', 'descriptor_name': 'Arachidonic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001095', 'descriptor_name': 'Arachidonic Acids', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D001681', 'descriptor_name': 'Biological Assay', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006168', 'descriptor_name': 'Guinea Pigs', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066298', 'descriptor_name': 'In Vitro Techniques', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007583', 'descriptor_name': 'Jejunum', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007583', 'descriptor_name': 'Jejunum', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009119', 'descriptor_name': 'Muscle Contraction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009292', 'descriptor_name': 'Narcotic Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009292', 'descriptor_name': 'Narcotic Antagonists', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010545', 'descriptor_name': 'Peroxides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011448', 'descriptor_name': 'Prostaglandin Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011453', 'descriptor_name': 'Prostaglandins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011453', 'descriptor_name': 'Prostaglandins', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/bf01957893', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210219280', 'display_name': 'Experientia', 'issn_l': '0014-4754', 'issn': ['0014-4754'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320186', 'host_organization_name': 'Birkhäuser', 'host_organization_lineage': ['https://openalex.org/P4310320186', 'https://openalex.org/P4310319900', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Birkhäuser', 'Springer Science+Business Media', 'Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/4631833', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.67, 'display_name': 'Life below water', 'id': 'https://metadata.un.org/sdg/14'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 13, 'referenced_works': ['https://openalex.org/W1997520378', 'https://openalex.org/W2017582608', 'https://openalex.org/W2022801299', 'https://openalex.org/W2051309246', 'https://openalex.org/W2060312923', 'https://openalex.org/W2061996572', 'https://openalex.org/W2143109864', 'https://openalex.org/W2276087198', 'https://openalex.org/W2397124930', 'https://openalex.org/W2411606343', 'https://openalex.org/W2411895856', 'https://openalex.org/W2434587790', 'https://openalex.org/W4254848357'], 'related_works': ['https://openalex.org/W77639234', 'https://openalex.org/W48649483', 'https://openalex.org/W4387206055', 'https://openalex.org/W2412460025', 'https://openalex.org/W2330402417', 'https://openalex.org/W2324422647', 'https://openalex.org/W2057332494', 'https://openalex.org/W2044887276', 'https://openalex.org/W1980066701', 'https://openalex.org/W1958432980'], 'abstract_inverted_index': {'«Narcotic': [0], 'analgesics»': [1, 19], 'und': [2], 'einzelne': [3], '«narcotic': [4, 18, 23], 'antagonists»': [5, 24], 'hemmen': [6], 'am': [7], 'isolierten': [8], 'Meerschweinchen-Jejunum': [9], 'durch': [10, 21], 'PGE1': [11], 'ausgelöste': [12], 'Kontraktionen.': [13], 'Die': [14], 'PGE1-antagonistische': [15], 'Wirkung': [16], 'der': [17], 'kann': [20], 'echte': [22], 'aufgehoben': [25], 'werden.': [26]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1970619144', 'counts_by_year': [{'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-08-15T03:46:15.308947', 'created_date': '2016-06-24'}